Market Research Blog – Page 1165 – New Product Development

Global Bronchoscopes Market Expected to Reach USD 647.7 Million by 2028 at a 4.4% of CAGR

According to Future Market Insights (FMI), the global Bronchoscopes Market size was valued at around USD 480.3 Million in 2021 and will grow 1.3X during the forecast period. During the projected period of 2022 to 2028, the market is expected to grow at a CAGR of 4.4%, with sales of USD 647.7 Million in 2028.

By the end of 2021, the global bronchoscopes market is predicted to account for about 4% of the global endoscopes market, which is expected to be valued at US $ 13.0 Billion in the same year. The rising prevalence of idiopathic pulmonary fibrosis, pulmonary fibrosis, interstitial pneumonitis, occupational sarcoidosis, and pulmonary haemorrhage is driving the global need for bronchoscopes and may create numerous prospects for manufacturers.

Cleaning conventional (multiple use) flexible bronchoscopes takes time and money, and there is a risk of cross infection. Cross-contamination is avoided by using a single-use flexible video bronchoscope. Early evaluation of the cost effectiveness of single-use bronchoscopes reveals possible hospital savings and patient advantages from prevented infections. Because of the appealing benefits, the increased use of single-use flexible bronchoscopes is creating a substantial market.

“Apart from the factors mentioned, technological advancements in the bronchoscopes landscape—witnessing a transformation shift from conventional invasive procedures to minimally invasive and advanced devices—is a critical factor determining the global demand for bronchoscopes, further amplifying its potential applications.

White-light bronchoscopy, Navigational bronchoscopy, and Autofluorescence (blue-light) bronchoscopy among others are some notable advancements and development, driving the global demand for bronchoscopes. Moreover, thin bronchoscopes with minimally invasive features are also gaining prominence. Manufacturers of bronchoscopes have built upon original bronchoscopes by making advancements, in terms of applicability and product versatility”, explains a senior analyst of the company.

Top Four Manufacturers Contribute the Largest Global Revenue

Considering the growing rate of technological advancements key manufacturers of broncoscopes, are making significant investments in the research and development initiatives to further increase the product efficiency. The global broncoscopes market showcases a highly competitive landscape characterized by relatively high barriers to entry, differentiated and well established products, and notable high profit margins.

Tier-1 manufacturers of bronchoscopes, including Olympus Corporation, FUJIFILM Holdings Corporation, Teleflex Incorporated, and HOYA Corporation, collectively hold a market share of approximately 62.5 percent—with Olympus Corporation contributing the largest revenue slice.

Tier-2 players such as KARL STORZ GmbH & Co KG, Ambu A/S, and Richard Wolf GmbH and tier-3 players including Rochling Group and Shanghai AoHua Photoelectricity Endoscope Co., Ltd, collectively contribute approximately 37.5 percent revenue share to the global bronchoscopes market. Key forward market strategies include:

With continued improvements in the global healthcare setting, key players seek acquisition opportunities as a key growth strategy. Olympus Corporation, Fujifilm Holdings Corporation, Teleflex Incorporated, and HOYA Corporation are likely to focus on mergers, acquisitions, and collaborations strategies, in the coming years. HOYA Corporation, for instance, acquired C2 Therapeutics, to expand its interventional endoscopy offerings in the U.S. and also provide aftersales and repair services.
Besides strategic tie-ups, new product launches will continue to be the key differentiation strategy, helping manufacturers to further solidify their market position. For instance, Olympus Corporation launched Truresolution objectives for multiphoton laser scanning microscopes. Teleflex Incorporated launched LMA® Gastro Airway, facilitating airway control during endoscopic procedures.
Leading manufacturers of bronchoscopes are also focusing on geographical expansions, specifically in emerging nations, by acquiring local players in the endoscopy market.

Critical Market Restrainers Identified

Risks of cross-contamination and post bronchoscopy infection in the form of bleeding, troubled breathing, and low blood oxygen level. FMI study indicates high infection rate at ambulatory surgical centers (ASCs), compared to clinics and hospitals.
Growing demand for non-invasive procedures including liquid biopsy and Magnetic Resonance Spectroscopy.
Stringency in regulations demanding a pre-market approval (PMA).

Bronchoscopes Market, By Category Product:

Non-Video Bronchoscopes
Video Bronchoscopes

Modality:

Rigid Bronchoscopes
Flexible Fiber Bronchoscopes
Mobile Bronchoscopes

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Growing Burden of Neurological Diseases Highlights Need for Innovative Treatments Like Vagus Nerve Stimulator Therapy

The rising prevalence of Vagus Nerve Stimulator Market in emerging countries has become a pressing health concern. According to estimates by the World Health Organization (WHO), between 4.5% and 11% of illnesses in both low- and high-income economies are attributed to neurological disorders. This alarming trend indicates a greater burden compared to patients suffering from respiratory ailments, gastrointestinal disorders, or cancers.

As the burden of neurological diseases is expected to increase further in the coming years, the consequences of neurological failure can be devastating, potentially leading to permanent paralysis or disability. Such conditions not only affect the patients but also impose significant challenges on their families and caregivers.

To address these complex health issues, Vagus Nerve Stimulator (VNS) therapy has been utilized for decades to alleviate symptoms associated with various neurological conditions, including tremors and dyskinesia. This innovative therapy works by creating muscle contractions that can help restore functionality to motor nerves.

In addition to improving motor functions, VNS therapy has shown promise in treating a variety of other neurological disorders, including migraines, Crohn’s disease, asthma, depression, headaches, and even certain cardiovascular diseases. As healthcare professionals continue to explore the potential of VNS therapy, its role in normalizing neurological functions and improving patient quality of life is increasingly recognized.

The growing need for effective treatments for neurological disorders underscores the importance of ongoing research and innovation in this field, paving the way for improved patient outcomes and a better quality of life.

For further information and insights on neurological treatments and innovations, please refer to upcoming publications and reports.

Driven by a paradigm shift from implantables to non/minimally invasive devices, the vagus nerve stimulator (VNS) landscape is gradually encouraging the growth of transcutaneous VNS to be witnessed over the next couple of decades. Moreover, growing R&D efforts in the integration of next-generation technology to bypass the shortcomings of implantable VNS is likely to shape the future of vagus nerve stimulator marketplace.

Of the total global population inflicted by neurological disorders, approximately 50% suffers from an epileptic disorder, research and surveys say.
Vagus nerve stimulation is witnessing a rapidly expanding applicability beyond epilepsy, in the recent past.
Research uncovers potential efficiency of vagus nerve stimulation in the obesity management of depression patients.
Positive outcome of vagus nerve stimulation in treatment-resistant depression and epilepsy surgery indicate promising opportunities approaching in the near future.

Europe Steals the Limelight, Crossing US$ 100 Million Revenue in 2019

North America currently holds a massive revenue share in the vagus nerve stimulator market, and FMi projects continued dominance of this region over other regional markets in comping years. However, the report forecasts emergence of Europe and Asia Pacific (excluding Japan) as highly attractive territories for key market players in the near future. Europe will reportedly cross the US$ 100 million mark in 2019, reflecting the most lucrative opportunities for vagus nerve stimulator manufacturers.

“At present, Europe and APEJ hold a collective revenue share of over 40% in market, of which the former is gradually moving towards extending its individual market value share up to 1/4^th of the global revenue,” explains a senior research analyst at FMI. Adding further, the analyst says, “Favorable regulatory and reimbursement scenario across Europe and relatively easy availability of VNS systems are most prominently driving the growth of vagus nerve stimulator market in Europe. VNS sales in Europe will also benefit from the strong presence of leading industry manufacturers in the region”.

Taxonomical Insights – By Type, Application, and End User

By the type of vagus nerve stimulator, implantable stimulator continues to bring in the most of the revenue to market.
Epileptic seizures secure the spot of the most sought after application type in vagus nerve stimulator landscape.
Hospitals remain the largest end user of vagus nerve stimulator. FMI research indicates that specialty clinics and home care settings are emerging as attractive end user candidates in recent years.

Thorough competition analysis of vagus nerve stimulator landscape reveals a few important developmental strategies that are ruling the minds of VNS manufacturers at present.

Besides geographical expansion, leading players in vagus nerve stimulator market are focusing on the extension of their existing offerings portfolio, according to the report.
In an effort to address the challenges to VNS adoption posed by the high price point, companies are now reassessing their pricing strategies for a competitive advantage.
A number of companies are also directing their strategic focus on a stronger distribution network.
Strategic partnerships with local and regional distributors and retailers hold immense importance for the competitors in VNS landscape.
Long-term contractual collaborations with recognized hospitals, research and pathology laboratories, and CROs are emerging as a growing trend among manufacturers of vagus nerve stimulator.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Recombinant Vaccines Market Set for Growth Amid Strategic Investments and Government Initiatives

Mature regional markets in North America and Europe remain differentiated due to effective presence of leading biopharmaceutical companies that boast of GMP certified sterile manufacturing facilities, contributing significant towards the revenue growth of Recombinant Vaccines Market in these regions.

Relatively safer and affordable, recombinant vaccines are gaining ground worldwide. With growing focus on preventive healthcare, vaccines are gathering momentum at a global level, including developing economies that still continue to struggle with severe demand-supply gap leading to a considerable shortfall in the availability of vaccines. However, a number of leading non-profit organizations are constantly initiating funding collaborations for improved accessibility of critical vaccines across developing countries.

A new Future Market Insights study on the global recombinant vaccines landscape highlights the optimistic revenue growth potential in developing regional markets such as Asia Pacific and Japan. The FMI report also offers an extensive analysis of the current competition scenario — emphasizing exclusive insights drawn by exhaustive primary and secondary market research.

Key Dynamics Analysis Evaluates the Role of Collaborative Activities and R&D

On the backdrop of how Sanofi’s acquisition of protein Sciences in 2017 has been boosting the former’s Flubok (recombinant vaccines for flu) manufacturing capacity, several players in recombinant vaccines space are strategizing mutual alliances in coming years. Strategic collaborations between leading players in the recombinant vaccines space is likely to provide a strong impetus to the overall market growth.

Moreover, according to WHO, growing prevalence of rare disease instances such as Ebola, Crimean Congo, MERS, hemorrhagic fever, Marburg, Lassa Fever, Nipah, SARS coronavirus diseases, and Rift Valley Fever is attracting R&D interests of recombinant vaccines manufacturers, thereby pushing growth of the market in the near future

FMI Study Positions Western Europe as Growth Engine of Recombinant Vaccines Landscape

Western Europe currently represents just-under 1/3rd share of the global market revenue, attributed to growing government support for vaccine development and vaccination campaigns. Strong presence of key market players in this region and their increasing investments in R&D of recombinant vaccines further accentuate Western Europe’s top performing spot.

The report projects impressive growth prospects for Asia Pacific and Japan in coming years. However, APAC is especially portrayed lucrative owing to dramatically growing healthcare spending and an expanding target population that struggles with highly unmet clinical needs, despite growing consumer awareness about vaccination merits.

Segmental Analysis Reveals Neck-on-Neck Competition between Subunit and Attenuated Vaccine Types

Based on the recombinant vaccines market assessment by type, subunit recombinant vaccines currently hold the largest value share but are likely to lose a bit of it to attenuated recombinant vaccines. Both the segments collectively cover around 90% share of the total market revenue.
Applications of recombinant vaccines in human vaccination continue to reflect maximum attractiveness over veterinary applications. A majority of the total market revenue is contributed by recombinant vaccines for humans, as indicated by the report.
Private clinics and dispensaries remain the most preferred channel for vaccines distribution, followed by pharmacies. Hospital pharmacies hold a larger share than retail pharmacies, though latter is poised for promising expansion in coming years.

Top Two Players Represent a Whopping 80% Market Value Share, Concludes Competition Analysis

According to the FMI study, GlaxoSmithKline plc and Merck & Co., Inc. collectively account for more than 80% revenue share in recombinant vaccines marketplace, keeping the landscape highly consolidated. While the former primarily focuses on strategic collaborations, the latter strategizes new product launches for an expanded market share.

GSK’s candidate vaccine launched in 2017 claims to prevent pulmonary TB in HIV negative adult patients.
Merck announced the three studies of the first phase of its investigational pneumococcal vaccine, early in 2018.

Competition tracking uncovers a few more important insights that can potentially direct strategy building efforts of competitors in the recombinant vaccines market at a global level.

New market entry aspirants are prominently opting for the adoption of mammalian protein expression systems in recombinant vaccines manufacturing that accelerate the entire production process.
Established players in recombinant vaccines landscape are prioritizing the development of new variants of existing vaccines.
Contractual alliances with non-profit organizations are likely to earn higher profit shares for manufacturing leaders in recombinant vaccines market.

Segmentation

The report on the recombinant vaccines market provides salient information on market players. The recombinant vaccines market is segmented by region, product type, application, and distribution channel, to analyze segment-wise growth of the recombinant vaccines market. Based on regions, the recombinant vaccines market is segmented into seven regions – North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

The recombinant vaccines market by product type is segmented intosubunit recombinant vaccines, attenuated recombinant vaccines, vector recombinant vaccines. By application, the recombinant vaccines market is segregated into human, and veterinary recombinant vaccines. By distribution channel, the recombinant vaccines market is segregated into hospitals, private clinics & dispensaries, retail pharmacies & others.

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Appendage Management Market Projected to Reach USD 352.5 Million by 2028 at a 6.6% of CAGR

The global appendage management market is estimated to grow from USD 223.9 million in 2021 to USD 352.5 million by the end of 2028, reflecting a CAGR of 6.6% during the forecast period.

This growth is fueled by the increasing demand for advanced medical solutions and technologies to manage appendage conditions, which are often linked to various health issues. As healthcare providers focus on improving patient outcomes and enhancing the quality of care, the appendage management market is set to experience significant expansion.

Key Market Drivers

The rising incidence of appendage-related disorders, combined with advancements in surgical techniques and treatment options, is driving market growth. Additionally, the growing awareness of preventive healthcare and the need for effective management of appendage conditions are contributing to the market’s upward trajectory.

For further insights into market trends and projections, Future Market Insights provides a comprehensive report on the appendage management market.

Key Insights on Competitive Landscape Analysis of Global Appendage Management Market

As per the FMI analysis, given the high revenue contribution by the top five players—including Boston Scientific Corporation, AtriCure, Inc., Abbott Laboratories, Cardia, Inc., and Medtronic plc—holding an accumulative revenue share of nearly 89 percent, the global appendage management market showcases a highly consolidated landscape. FMI’s research also indicates that smaller players contribute approximately 11.5 percent of revenue share to the global appendage management market. A much more careful competitive landscape analysis of the global appendage management market reveals a 3-tier segmentation—depending upon the growth stage of various companies.

With reach wide enough in North America, Boston Scientific Corporation and AtriCure, Inc. are the clear market leaders—for endocardial and epicardial left atrial closure devices, respectively. With an accumulative share of approximately 57 percent in the appendage management market, Boston Scientific Corporation’s WATCHMAN and AtriCure, Inc.’s products are in direct competition. However, WATCHMAN is most widely implanted and trusted—boasting FDA approval and CE Mark
Mid-stage growth companies including Abbott Laboratories and Cardia, Inc have pulled away from the top two players, in the last few years—holding approximately 32 percent market share. These companies, however, have an expansive range of product offerings. Holding nearly 14 percent in terms of revenue, Abbott Laboratories is upping its portfolio of upper and lower extremities along with popularization of the product with good clinical trial results.
The emerging players, including SentreHEART, Inc., LifeTech Scientific Co., Ltd, Occlutech International AB, and Johnson & Johnson Services, Inc. are more focused on product innovation and differentiation within certain treatment niches, to build a strong market position in the consolidated appendage management landscape. In spite of a miniscule market share, FMI foresees notable potential of their research and development initiatives in the long run.

In terms of overall forward market strategies, key companies are projected to focus on innovating easily implantable, life-saving products for patients suffering from atrial fibrillation, thereby, eliminating the side-effects caused by drugs taken to treat atrial fibrillation. Innovative devices and better navigation and visualization technologies are expected to bring significant opportunities—translating into increased adoption of Left Atrial Appendage (LAA) closure devices by catheterization laboratories and hospitals.

Moreover, mergers and acquisitions will remain a key expansion strategy among players in appendage management market. FMI indicates that acquisitions in the global appendage management market would prove beneficial for the key leaders considering the increasing number of promising on-going or successful researches by emerging companies. Already in a dominant position, key players are increasingly focusing in strengthening the supply chain and distribution networks through strategic partnerships to maximize their market share.

Bonus: Key Market Influencers

Notable success rate of appendage management procedures.
Non-surgical, minimal invasion approach helping in fast recovery and reduced surgical and implantation complications.
Drawback of oral anticoagulant drugs to push the demand for appendage management procedures.

Appendage management market by Category By Product Type

Epicardial LAA Closure Devices
Endocardial LAA Closure Device

By End User

Hospitals
Cath Labs

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Endoscopy Fluid Management Systems Market Set to Reach USD 683 Million by 2028 at a 7.4% of CAGR

The global endoscopy fluid management systems market was valued at USD 414 million in 2021 and is projected to experience robust growth, reaching an estimated USD 683 million by 2028. The market is anticipated to expand at a CAGR of 7.4% during the forecast period.

This growth can be attributed to the increasing adoption of endoscopic procedures and the rising demand for advanced medical technologies that enhance surgical outcomes. Endoscopy fluid management systems play a critical role in maintaining optimal fluid levels during procedures, which is essential for ensuring patient safety and improving procedural efficiency.

Key Market Drivers

The rising prevalence of chronic diseases, coupled with an aging population, is driving the demand for minimally invasive surgical techniques, further boosting the need for effective fluid management solutions. Innovations in endoscopy technologies and the growing emphasis on improving patient care are also contributing to the market’s expansion.

For a detailed analysis of market trends and future projections, Future Market Insights offers comprehensive insights into the endoscopy fluid management systems market.

Prominent Players:

Karl Storz GmbH & Co KG
Olympus Corporation
Richard Wolf GmbH
Smith & Nephew
Stryker Corporation
DePuy Synthes (Johnson & Johnson Services Inc.)
Cantel Medical Corporation
Medtronics Plc.
B. Braun Medical Inc. and Hologic Inc

Healthy Year over Year Revenue Growth Projected for Asia Pacific

APAC has become the hotspot for leading medical device companies, which is further intensified by dramatically growing medical tourism sector. Across APAC, Japan is likely to account for substantial revenue generation, enabling the regional market secure second spot in the global endoscopy fluid management systems landscape. FMI projects over 7% year on year revenue growth in 2020 and beyond, for this regional market.

Government Regulations Favor Market Growth in Latin America

Latin American market for endoscopy fluid management systems is thriving at a promising pace owing to favorable government initiatives regarding endoscopic procedures and medical device marketing. Noteworthy demand for laparoscopy suction irrigation pumps within the region is identified to be responsible for the rapid revenue growth of endoscopy fluid management systems marketplace across Latin America.

Key Segments Covered in Endoscopy Fluid Management Systems Industry Survey:

Endoscopy Fluid Management Systems Market by Product Type:

Laparoscopy endoscopy fluid management systems
Hysteroscopy endoscopy fluid management systems

Endoscopy Fluid Management Systems Market by Modality:

Floor Standing endoscopy fluid management systems
Benchtop fluid management systems

Endoscopy Fluid Management Systems Market by End-User:

Hospitals endoscopy fluid management systems
Ambulatory surgical centers endoscopy fluid management systems
Specialty clinics endoscopy fluid management systems
Diagnostic centers endoscopy fluid management systems

Endoscopy Fluid Management Systems Market by Region:

North America endoscopy fluid management systems Market
Latin America endoscopy fluid management systems Market
Europe endoscopy fluid management systems Market
East Asia endoscopy fluid management systems Market
South Asia & Pacific endoscopy fluid management systems Market
Middle East & Africa (MEA) endoscopy fluid management systems Market

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Narcolepsy Treatment Industry Poised for USD 6.67 Billion Valuation by 2028, Driven by a 5.7% CAGR

The Global Narcolepsy Treatment Industry From an expected USD 4.77 billion in 2022, the market for narcolepsy treatment is projected to grow at a CAGR of 5.7% to reach USD 6.67 billion by 2028. (2022-2028).

In its recently released market intelligence overview, Future Market Insights (FMI) underlines the significant need for narcolepsy treatment in North America. Given the growing inclination towards the use of prescription medicines and adherence to the same on a long-term basis, the narcolepsy treatment landscape in Europe will experience significant revenue growth.

The neurobiology of sleep has advanced significantly over the past few decades, mostly as a result of the proliferation of animal models for investigating the neurological functions of the brain and any potential complexities. This also takes into account the part the brain plays in sleep.

Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:

Strong distribution pipeline of narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
The prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
The prevalence of sleep apnea is more severe in developing countries due to the lack of skilled physicians

In terms of key forward market strategies, the primary objective of manufacturers in the Global Narcolepsy Treatment Industry is to expand their footprint in the various regional markets, to solidify their market position.

Key Findings from the Regional and Competitive Landscape Analysis of the Global Narcolepsy Treatment Industry

Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low-cost generic versions of patented drugs, strategic partnerships and acquisitions with pave the way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused on introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospitals and retail, drug stores, and e-commerce. Sales through an e-commerce distribution channel are expected to contribute a significant revenue share in the Global Narcolepsy Treatment Industry.
FMI has also noted an increasing focus on the reformulation of well-known products and combinations, by manufacturers in North America to achieve higher sales and wide penetration

There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs. Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids.

Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home-based unit, further reducing the dependency on OTC pills and prescription drugs.

While explaining the growth trajectory of the Global Narcolepsy Treatment Industry, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand for narcolepsy treatment through 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations, and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.

Critical Market Restrainers

Although the narcolepsy market is expanding at a robust CAGR, long waiting times for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aid medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of Global Narcolepsy Treatment Industry.

Key Market Segments Covered in Global Narcolepsy Treatment Industry Research

By Product:

Narcolepsy Treatment Drugs
- Modafinil
- Sodium Oxybate
- Armodafinil
- Others
Devices
- CPAP Devices
- BiPAP Devices
- APAP Devices

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
e-commerce
Drug Stores
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

GigE Camera Market 2022 | Present Scenario and Growth Prospects 2032

The global GigE camera market size is anticipated to develop at a CAGR of 9.1% from 2022 to 2032, reaching US$ 5.8 billion. In 2022, its estimated worth will be US$ 3.5 billion. Sales of GigE cameras are expected to increase in the coming years as a result of these cameras’ capacity to transport data swiftly during certain tasks that call for the use of numerous cameras.

GigE Camera or Gigabit Ethernet Camera is the image camera which has an ability to interface with computer system using GigE port. GigE cameras are based on GigE vision standards developed specifically for cameras which transmit images over gigabit Ethernet.

GigE cameras have ability to transfer data up to 1000MB/s which makes it favourable for many demanding applications. GigE cameras are predominantly used for applications which requires high rate of data transfer through long cable distances.

The GigE camera is a very affordable solution with simple configuration possibilities because it does not require a frame grabber, unlike many previous interface technologies. Over the course of the forecast period, all of these benefits are anticipated to contribute to the GigE camera market’s swift expansion.

GigE Camera Market: Drivers & Restraints

GigE camera market is expected to show significant growth during the period of forecast. Factors which are driving the growth of global GigE camera market are fast data transfer speed, decreasing development cost and efficient video transmission with easier configuration options.

On the other hand, increased CPU load and necessity of universal driver for interoperability are the restraints for the growth of global GigE camera market. However, adoption of 3D vision technologies and move towards smart camera based system creates great opportunity for global GigE camera market

GigE Camera Market: Region wise outlook

By region, the global GigE camera market can be segmented into seven regions namely, North America , Latin America, Asia-Pacific excluding Japan, Western Europe, Japan as a separate region, Eastern Europe and Middle East & Africa. Out of all this regions, present global GigE camera market is dominated by North America region in terms of value.

In North America region, non-manufacturing applications of GigE cameras such as security & surveillance, intelligent transportation and medical imaging are dominating. It is mainly because of high infrastructural development and high adoption of advanced technology. On the other hand Asia Pacific region is estimated to grow rapidly during the period of forecast.

Market Competition

Some of the key players operating in the global GigE camera are Toshiba Corporation, Allied Vision Technologies GmbH, Sony Corporation, Basler AG, Teledyne DALSA Inc., Baumer, Qualitas Technologies, IMPERX, Inc., Omron Corporation, and Matrox Imaging.

The global market is highly fragmented with the presence of several renowned companies providing their in-house products. Many vendors are focusing on the rapid adoption of the new product launch strategy with less product differentiation in terms of offerings. A few other key players are aiming to engage in mergers and acquisitions with start-up companies and local firms to strengthen their footprint in the global market.

Request a Sample of this Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-715

Key Segments Profiled in the GigE Camera Industry Survey

By Technology:

Complementary Metal- Oxide — Semiconductor (CMOS)
Charge Coupled Device (CCD)

By Type:

Line Scan
Area Scan

By Color Sensor Type:

Color
Monochrome

By End User:

Military and Defense
Industrial
Pharmaceutical
Traffic, Security & Surveillance
Medical/Life Sciences
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vein Finder Market to Reach USD 52.4 Million by 2034 at a 3.4% of CAGR

The global vein finder market is projected to witness consistent growth over the next decade, with market value increasing from USD 37.6 million in 2024 to USD 52.4 million by 2034, according to the latest industry analysis. The market is expected to register a CAGR of 3.4% during the forecast period.

In 2023, the global vein finder market was valued at US$ 37.5 million, and it is forecasted to exhibit year-over-year growth of 7.0% in 2024. Over the long term, total vein finder revenue is expected to grow 1.4x by 2034.

In 2023, the global vein finder industry was valued at $37.5 million, and it is anticipated to experience a robust year-on-year growth rate of 7.0% in 2024. This strong performance underscores the increasing demand for vein finders, driven by advancements in medical technology and an expanding healthcare sector.

The total revenue from vein finders is projected to grow by 1.4 times by 2034, highlighting the market’s potential for significant expansion. This growth is attributed to the rising adoption of vein finders in clinical settings, improved technology, and a greater focus on enhancing patient care through innovative medical devices.

“Innovations like these are expected to increase adoption of advanced Vein Finders in hospitals and healthcare establishments, leading to significant revenue growth of the Global Vein Finder Industry. Our analysis of the performance of the Vein Finder market reveals an absolute $ opportunity of US$ 3.0 Million between 2018 and 2019 and the global market is estimated to register a stellar growth rate of 10.9% in the coming decade.” Practice Head – Healthcare & Medical Devices, Future Market Insights

Global Vein Finder Industry Structure Overview: Regional Focus to Bolster Global Market Growth

An overview of the market structure of the Global Vein Finder Industry reveals a strong regional presence of top market companies as well as local players. Leading companies operating in the Global Vein Finder Industry are leveraging acquisitions as a primary strategy to facilitate regional market expansion. Future Market Insights analysis also observes a strong focus by Vein Finder companies on R&D for new product development and expansion of the existing product line in key regional growth markets.

“Implementation of inorganic growth strategies is seen as the way forward to penetrate key growth markets across certain developing regions. Companies in the Vein Finder market with diversified product offerings are collaborating with local regional players to introduce low-cost Vein Finder products to cement their presence across top regional markets.”

In 2017, the leading three companies in the Global Vein Finder Industry held a revenue share of about 56% while the remaining players contributed about 44% market share. New product development is a key strategy adopted by players in the Global Vein Finder Industry to increase their brand value. Rising difficulties associated with peripheral venous access, venepuncture is one of the primary factors boosting the growth of the Global Vein Finder Industry, and key players are capitalizing on the growth drivers to increase their market share.

Future Market Insights predicts lucrative revenue growth in the various regional markets of Europe and Asia Pacific Excluding Japan. Europe will likely remain the top market for sales of Vein Finder devices owing to the increasing adoption of Vein Finder across hospitals and clinics to locate veins for drawing blood samples, IV insertions, and other vascular procedures.

Portable Vein Finder to Garner Maximum End User Demand; Infrared Technology to Register Fastest Growth in Revenue

Portable Vein Finders are likely to be the most preferred product type in the Global Vein Finder Industry, registering impressive demand as well as sales growth in the coming decade. The convenience and ease of use offered by portable Vein Finders is the primary factor boosting adoption across hospitals, clinics, and other healthcare institutions. The Global Vein Finder Industry is fuelled by advanced technology with infrared technology being the most adopted in Vein Finders. Among the various end users of Vein Finders, hospitals are likely to exhibit the highest demand in the next 10 years, also contributing to maximum revenues in the global Vein Finder market.

Vein Finder Market Competitive Landscape

The market for Vein Finders is fragmented by nature, with only a few players present. These players are part of several strategic alliances. The product launch and acquisition speed up the manufacturer’s strategy to capitalize on market share and gain a sizable market share.

Furthermore, the corporations are focusing on the launch of new items to boost their product portfolio in the Asia Pacific area to expand their clientele and capture the largest market share in emerging economies.

Vein Finder Market Key Players

AccuVein Inc.
Christie Medical Holdings
Koninklijke Philips N.V
Osang Healthcare Co. Ltd
Teleflex Inc. (Acq. VueTek Scientific, LLC.)
TransLite, LLC
ZD Medical
Vivolight
Venoscope LLC
Shenzhen Bestman Instruments Co., Ltd

A Old Full Report Analysis Click Here

Vein Finder Market by Category

By Product:

Portable
Benchtop

By Technology:

Ultraviolet
Infrared
Ultrasound

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Centers and Path Labs
Veterinary Clinics
Home Care Settings
Blood Banks

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Soaring Demand for Silicon Photonics Driven by Wide Range of Applications – Markets Estimated to Reach $6 Billion by 2032

The silicon photonics market is estimated to grow at a remarkable Compound Annual Growth Rate (CAGR) of over 26.0% between 2022 and 2032. This indicates that the market is anticipated to perform spectacularly in the years to come. It is anticipated that this quickly growing industry would be valued at around US$ 1.3 billion in 2022 and US$ 6 billion by 2032.

A state-of-the-art technique that use silicon as an optical medium is called silicon photonics. Due to its potential to increase data transmission speeds and internet bandwidth, silicon photonics has attracted a lot of interest from several industries. This method, which builds photonic integrated circuits by fusing silicon and laser, is quickly becoming a standard feature of modern electronic devices.

The demand for silicon photonics products has witnessed an upsurge across diverse sectors, including consumer electronics, IT, and telecommunications. This demand is primarily driven by the need for faster data transmission, greater bandwidth, and reduced power consumption. In recent years, products like silicon photonic transceivers have gained popularity as they offer the potential to achieve faster data transmission rates while consuming less power.

Don’t Miss Out on Valuable Insights – Sample! : https://www.futuremarketinsights.com/reports/sample/rep-gb-651

One of the prominent applications of silicon photonics is in high-performance computers and data centers, which are experiencing an unprecedented surge in demand due to the growing adoption of cloud computing. As data traffic increases across businesses, there is a pressing need for faster data transmission solutions such as silicon photonics. Consequently, data center operators are increasingly embracing technologies like CMOS integrated silicon photonics to meet this demand effectively.

Silicon Photonics Market: Drivers & Restraints

The largest market for global silicon photonics market is data communication, as the protocol is providing services which is surpassing optical and copper technologies. The government providing financial support and the growing demand for the transference of data is driving the growth of global silicon photonics market.

Demand for global silicon photonics market is also driven by covering distance or data rates which have not been provided by vertical cavity surface-emitting lasers (VCSELs), providing faster data rates while maintaining low cost. Various constraints for the global silicon photonics market are high cost as the companies have to develop the Computer-aided engineering/Computer-aided design (CAE/CAD) on their own and competition with VCSEL which is available at a low cost.

Silicon Photonics Market: Region-wise Outlook

In terms of region, North America has the highest market for silicon optical modulators and wavelength division multiplexer filters. North America is becoming an attractive destination for the companies to launch the silicon photonics market due to government support and increase in demand for the data transfer but Asia-Pacific has the highest CAGR for global silicon photonics market due to rising population, increase in urbanization and growing demand for data transfer.

Market Competition

Some of the key participants present in the global silicon photonics market include Infinera, NeoPhotonics, Avago Technologies, Luxtera, Mellanox Technologies, OneChip Photonics, Cisco, Skorpios Technologies, Photline Technologies among others.

These market leaders are always spending in R&D operations in order to introduce innovative goods with efficient features. For example, Ranovus Inc., a major manufacturer of multi-terabit interconnect solutions for data centres and communications networks, will unveil an advanced silicon photonic device in March 2020. Aside from that, they are expanding their global presence through various growth strategies such as partnerships, the establishment of facilities in desirable regions, and collaborations.

Key Segments Profiled in the Silicon Photonics Industry Survey

Products:

Silicon Optical Modulators
Wavelength Division Multiplexer Filters
Silicon Photo-Detectors
Silicon Photonic Waveguides
Others (silicon led, silicon optical interconnects etc.)

Application:

Telecommunications
Datacom
High performance Computer (HPC) and Data Centers
Medical
Sensing and Instruments
Defense/Aerospace Industries
Research and Development
Others (consumers-connecting PCs with HDTVs and desktop PC devices, commercial video, etc.)

Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East & Africa

Don’t Miss Out on Expertise: Grab Your Copy of the Report Now! https://www.futuremarketinsights.com/checkout/651

About Future Market Insights (FMI)

Contact Us:

Product Design Verification and Validation Solution Market Poised for Robust Growth

The market for product design verification and validation solutions is expanding at a promising CAGR and is anticipated to keep up its momentum over the coming years.

Global sales of solutions for product design verification and validation are anticipated to increase. There is an increasing need for design items that are more effective and of higher quality. Additionally, there is a growing need for product design verification and validation solutions in the manufacturing, healthcare, retail, and industrial sectors. Smart devices and automated machinery are being developed and adopted at a faster rate.

Increasing manufacturing industry growth is also projected to contribute to the growth of the Product design verification and validation solution market share.

Some key product design verification and validation solution market trends promoting the demand for product design verification and validation solution include how these solutions incorporate advanced technology such as machine learning, big data, and artificial intelligence.

What are the Key Contributors to the Product Design Verification And Validation Solution Market Share?

The demand for product design verification and validation solutions is anticipated to increase at a robust pace over the forecast period (2022-2032). Growth in the market is attributed to the increasing need for efficient and improved design-quality products worldwide.

Verification and validation of products are two separate procedures extensively used by end-users to cross-check the quality of products and services. The expansion of manufacturing and retail sectors is increasing the need for improved quality of products.

To cater to the growing system requirements, industries are increasing the adoption and sales of product design verification and validation solutions. Evaluation of product’s design and quality on the basis of specific development, design requirement, and conditions.

With the growing need for advanced products and customized requirements, especially in IT & telecom, healthcare, and manufacturing industries, key companies are developing advanced solutions for verifying and validating the design and quality of the product.

The sales of product design verification and validation solutions witnessed an uptick through 2021 amid growing demand for specific COVID-19 medicines and vaccination. Leading healthcare companies implemented advanced verification and validation solutions for efficient medicines to adhere to the surging demand for product design verification and validation solution.

Besides this, rapid digitization and automation in the public and manufacturing sector are also propelling the demand for product design verification, and validation solutions are slated to rise over the coming years.

Growing production and adoption of smart devices and automated equipment in healthcare, retail, manufacturing, and industrial sectors are the major factors driving the demand for product design verification and validation solutions.

Additionally, the integration of advanced technology such as machine learning, big data, and artificial intelligence in these solutions is increasing sales in the market. With the surging expansion of the manufacturing industry and the development of industrial automated equipment, end users are implementing verification process solutions to determine the quality of the products.

They are also adopting solutions that verify the product quality as per the consumer’s requirement to improve efficiency and reduce latency. This is projected to fuel the sales of product design verification and validation solutions.

Which Region holds the Highest Growth Potential in the Product Design Verification And Validation Solution Market?

As per Future Market Insights (FMI), Asia Pacific is expected to emerge as the most lucrative product design verification and validation solution market. Rapid development in the manufacturing and healthcare industries, especially across India and China, will fuel the demand for product design verification and validation solution.

The expansion of the retail sector and booming commercial industry in India is propelling the demand for improved quality products with specific requirements. Consumers are becoming increasingly aware of the products they require, enabling the increased sales of product design verification and validation solutions.

Backed by these factors, the Asia Pacific demand for product design verification and validation solutions is slated to witness growth at a significant rate during the assessment period.

According to FMI, the North American sales of product design verification and validation solution are projected to account for the lion’s share between 2022 and 2032.

Ongoing advances in the manufacturing, transportation, and IT sectors are driving the demand for product design verification and validation solutions.

Increasing demand for automation in these sectors and the need for efficient products will promote growth in North America. Demand for product design verification and validation solutions is expected to increase with the heavy presence of industries and key players in the U.S.

As per the study, the U.S. is projected to spearhead the growth in North American product design verification and validation solutions sales.

How is the Competitive Landscape in the Product Design Verification and Validation Solution Market?

Some of the key participants present in the global product design verification and validation solution market include Igate Patni Ltd., MathWorks Inc., Tech Mahindra Ltd., Intent Design Pvt Ltd., The RealTime Group Inc., and IVT Network Limited, among others.

According to the study, the market is projected to be highly competitive due to the rise in demand for product design verification and validation solutions with numerous leading players. Key players are collaborating with end users to cater to the surging demand for product design verification and validation solution for these solutions.

Some of the players are adopting strategies such as mergers & acquisitions and product development to increase their sales of product design verification and validation solution. They are also integrating advanced technologies such as big data science and real-time analytics to improve the efficiency of the products.

Key segments covered in Product Design Verification and Validation Solution (PDVVS) market report

Component:

Solution
Services

Application:

Product Reliability Testing
Risk Assessment
Prototype Testing
Environment Testing

Verticals:

Aerospace & Defense
Automotive
Medical
Industrial Automation
IT & Telecom

Region:

U.S.
U.K.
India
China
Japan

Request a Sample of This Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-787

About Future Market Insights (FMI)

Contact Us: